Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1195

Chymosin enzyme preparation produced by Aspergillus niger expressing a gene encoding chymosin from Erinaceus europaeus

Intended Use: Intended for use as an enzyme at up to 0.97 mg Total Organic Solids (TOS)/kg milk in cheese and whey powder production.
Basis: Scientific procedures
Notifier: Chr. Hansen A/S
Notifier Address: Boege Allé 10-12
Hoersholm 2970
Denmark
GRAS Notice (releasable information): GRN 1195 with amendments (in PDF) (4.4 MB)
Date of closure: Mar 6, 2025
Date of FDA’s corrected letter: Jul 3, 2025
FDA's Letter: FDA has no questions (in PDF) (334 kB)
Additional correspondence: Jul 3, 2025
Correction Letter (in PDF) (192 kB)
-
-